Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

For COPD patients with a nutritional goal to lose weight, some simple approaches can do a lot of good, Mosher noted, pointing ...

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Dr. Albert J. Polito from Mercy Medical Center joins Jenyne for a conversation about lung conditions such as COPD and asthma and how they present in female patients.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds ...